Cargando…
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods
SIMPLE SUMMARY: High-grade serous ovarian cancer (HGSOC) is the deadliest gynecological malignancy. Despite increasing research on HGSOC, biomarkers for individualized selection of therapy are scarce. In this study, we develop a multiparametric mass cytometry antibody panel to identify differences i...
Autores principales: | Anandan, Shamundeeswari, Thomsen, Liv Cecilie V., Gullaksen, Stein-Erik, Abdelaal, Tamim, Kleinmanns, Katrin, Skavland, Jørn, Bredholt, Geir, Gjertsen, Bjørn Tore, McCormack, Emmet, Bjørge, Line |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918057/ https://www.ncbi.nlm.nih.gov/pubmed/33670410 http://dx.doi.org/10.3390/cancers13040755 |
Ejemplares similares
-
Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study
por: Thomsen, Liv Cecilie Vestrheim, et al.
Publicado: (2023) -
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022) -
CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
Titrating Complex Mass Cytometry Panels
por: Gullaksen, Stein‐Erik, et al.
Publicado: (2019) -
The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
por: Kleinmanns, Katrin, et al.
Publicado: (2020)